{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T04:41:06Z","timestamp":1649047266978},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1007\/s00108-006-1701-0","type":"journal-article","created":{"date-parts":[[2006,8,9]],"date-time":"2006-08-09T10:26:48Z","timestamp":1155119208000},"page":"901-907","source":"Crossref","is-referenced-by-count":0,"title":["Stadiengerechte Therapie der COPD"],"prefix":"10.1007","volume":"47","author":[{"given":"H.","family":"Hamm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1701_CR1","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1056\/NEJMoa023161","volume":"348","author":"Aaron","year":"2003","unstructured":"Aaron SD, Vandemheen KL, Hebert P (2003) Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. New Engl J Med 348: 2618\u20132625","journal-title":"New Engl J Med"},{"key":"1701_CR2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1513\/pats.200504-035SR","volume":"2","author":"Adcock","year":"2005","unstructured":"Adcock IM, Ito K (2005) Glucocorticoid pathways in chronic obstructive pulmonary disease therapy. Proc Am Thorac Soc 2: 313\u2013319","journal-title":"Proc Am Thorac Soc"},{"key":"1701_CR3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1183\/09031936.05.00102604","volume":"26","author":"Anthonisen","year":"2005","unstructured":"Anthonisen NR, Lindgren PG, Tashkin DP et al. (2005) Bronchodilator response in the lung health study over 11 yrs. Eur Respir J 26: 45\u201351","journal-title":"Eur Respir J"},{"key":"1701_CR4","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1183\/09031936.05.00139104","volume":"25","author":"Barnes","year":"2005","unstructured":"Barnes PJ, Stockley RA (2005) COPD: Current therapeutic interventions and future approaches. Eur Respir J 25: 1084\u20131106","journal-title":"Eur Respir J"},{"key":"1701_CR5","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1136\/bmj.320.7245.1297","volume":"320","author":"Burge","year":"2000","unstructured":"Burge PS, Calverley PMA, Jones PW (2000) Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 320: 1297\u20131303","journal-title":"BMJ"},{"key":"1701_CR6","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(03)12459-2","volume":"361","author":"Calverley","year":"2003","unstructured":"Calverley P, Pauwels R, Vestbo J et al. (2003) Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 361: 449\u2013456","journal-title":"Lancet"},{"key":"1701_CR7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1183\/09031936.02.00269802","volume":"19","author":"Casaburi","year":"2002","unstructured":"Casaburi R, Mahler DA, Jones PW et al. (2002) A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 19: 217\u2013224","journal-title":"Eur Respir J"},{"key":"1701_CR8","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0140-6736(98)11326-0","volume":"354","author":"Davies","year":"1999","unstructured":"Davies LR, Angus M, Calverley PMA (1999) Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomized controlled trial. Lancet 354: 456\u2013460","journal-title":"Lancet"},{"key":"1701_CR9","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0140-6736(05)66456-2","volume":"365","author":"Decramer","year":"2005","unstructured":"Decramer M, Rutten-von-Molken MPMH, Dekhuijzen PNP et al. (2005) Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial. Lancet 365: 1552\u20131560","journal-title":"Lancet"},{"key":"1701_CR10","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1136\/bmj.1.6077.1645","volume":"1","author":"Fletcher","year":"1977","unstructured":"Fletcher C, Peto R (1977) The natural history of chronic airflow obstruction. BMJ 1: 1645","journal-title":"BMJ"},{"key":"1701_CR11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1378\/chest.124.2.459","volume":"124","author":"Groenewegen","year":"2003","unstructured":"Groenewegen KH, Schols AM, Wouters EF (2003) Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 124: 459\u2013467","journal-title":"Chest"},{"key":"1701_CR12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1513\/pats.200504-036SR","volume":"2","author":"Gross","year":"2005","unstructured":"Gross NJ (2005) Chronic obstructive pulmonary disease outcome measurements. What\u2019s important? What\u2019s useful? Proc Am Thorac Soc 2: 267\u2013271","journal-title":"Proc Am Thorac Soc"},{"key":"1701_CR13","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199903043400903","volume":"340","author":"Jorenby","year":"1999","unstructured":"Jorenby DE, Leischow SJ, Nides MA et al. (1999) A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 340: 685\u2013691","journal-title":"N Engl J Med"},{"key":"1701_CR14","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1164\/rccm.200508-1211ST","volume":"173","author":"Nici","year":"2006","unstructured":"Nici L, Donner C, Wouters E et al. (2006) ATS\/ERS Statement on pulmonary rehabilitation. Am J Respir Crit Care Med 173: 1390\u20131413","journal-title":"Am J Respir Crit Care Med"},{"key":"1701_CR15","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJM199906243402502","volume":"340","author":"Niewoehner","year":"1999","unstructured":"Niewoehner DE, Erbland ML, Deupree RH (1999) Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. New Engl J Med 340: 1941\u20131947","journal-title":"New Engl J Med"},{"key":"1701_CR16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/0003-4819-143-5-200509060-00007","volume":"143","author":"Niewoehner","year":"2005","unstructured":"Niewoehner DE, Rice K, Cote C et al. (2005) Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator. Ann Intern Med 143: 317\u2013326","journal-title":"Ann Intern Med"},{"key":"1701_CR17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.7326\/0003-4819-93-3-391","volume":"93","author":"Nocturnal","year":"1980","unstructured":"Nocturnal oxygen therapy trial group (1980) Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease: a clinical trial. Ann Intern Med 93: 391\u2013398","journal-title":"Ann Intern Med"},{"key":"1701_CR18","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(97)03471-5","volume":"351","author":"Paggiaro","year":"1998","unstructured":"Paggiaro PL, Dahle K, Bakran I et al. (1998) Multicentre randomized placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. Lancet 351: 773\u2013780","journal-title":"Lancet"},{"key":"1701_CR19","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(05)67100-0","volume":"366","author":"Rabe","year":"2005","unstructured":"Rabe KF, Bateman ED, O\u2019Donnell D et al. (2005) Roflumilast \u2013 an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 366: 563\u2013571","journal-title":"Lancet"},{"key":"1701_CR20","first-page":"CD000238","volume":"2","author":"Ram","year":"2002","unstructured":"Ram FS, Wedzicha JA (2002) Ambulatory oxygen for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2: CD000238","journal-title":"Cochrane Database Syst Rev"},{"key":"1701_CR21","first-page":"681","volume":"1","author":"Report","year":"1981","unstructured":"Report of the medical research council working party (1981) Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1: 681\u2013686","journal-title":"Lancet"},{"key":"1701_CR22","first-page":"381","volume":"161","author":"Scanlon","year":"2000","unstructured":"Scanlon PD, Connett JE, Waller LA (2000) Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. AJRCCM 161: 381\u2013390","journal-title":"AJRCCM"},{"key":"1701_CR23","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1164\/ajrccm.164.4.2009033","volume":"164","author":"Sin","year":"2001","unstructured":"Sin DD, Tu JV (2001) Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164: 580\u2013584","journal-title":"Am J Respir Crit Care Med"},{"key":"1701_CR24","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1136\/thx.2005.045385","volume":"60","author":"Sin","year":"2005","unstructured":"Sin DD, Wu L, Anderson JA et al. (2005) Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax 60: 992\u2013997","journal-title":"Thorax"},{"key":"1701_CR25","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/thorax.58.11.937","volume":"58","author":"Sutherland","year":"2003","unstructured":"Sutherland ER, Allmers H, Ayas NT (2003) Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis. Thorax 58: 937\u2013941","journal-title":"Thorax"},{"key":"1701_CR26","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1183\/09031936.03.00031402","volume":"21","author":"Szafranski","year":"2003","unstructured":"Szafranski W, Cukier A, Ramirez A et al. (2003) Efficacy and safety of budesonide\/formoterol in the management of chronic obstructive pulmonary disease. Eur Respir J 21: 74\u201381","journal-title":"Eur Respir J"},{"key":"1701_CR27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1164\/rccm.200408-1109SO","volume":"172","author":"Troosters","year":"2005","unstructured":"Troosters T, Casaburi R, Gosselink R, Decramer M (2005) Pulmonary rehabilitation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 172: 19\u201338","journal-title":"Am J Respir Crit Care Med"},{"key":"1701_CR28","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1164\/rccm.200206-512OC","volume":"166","author":"van der Valk","year":"2002","unstructured":"van der Valk P, Monninkhof E, van der Palen J et al. (2002) Effect of disconuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166: 1358\u20131363","journal-title":"Am J Respir Crit Care Med"},{"key":"1701_CR29","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1183\/09031936.05.00140404","volume":"26","author":"van Noord","year":"2005","unstructured":"van Noord JA, Aumann JL, Janssens E et al. (2005) Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD. Eur Respir J 26: 214\u2013222","journal-title":"Eur Respir J"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-006-1701-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-006-1701-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-006-1701-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T04:11:37Z","timestamp":1558584697000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-006-1701-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["1701"],"URL":"https:\/\/doi.org\/10.1007\/s00108-006-1701-0","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}